Skip to main content
. 2008 Nov 12;47(1):117–123. doi: 10.1128/JCM.01747-08

TABLE 4.

Geographic variation in azole resistance among selected non-Candida yeastsa

Region Antifungal agent C. neoformans
S. cerevisiae
Trichosporon spp.
Rhodotorula spp.
n % R n % R n % R n % R
Asia-Pacific Fluconazole 530 10.8 25 24.0 175 8.6 149 21.5
Voriconazole 502 3.0 24 12.5 175 4.0 147 15.0
Europe Fluconazole 470 6.6 902 5.1 415 12.3 103 71.8
Voriconazole 456 1.5 893 2.4 401 3.5 103 62.1
Africa/Middle East Fluconazole 869 12.4 16 0.0 37 0.0 16 87.5
Voriconazole 868 1.8 16 0.0 37 0.0 16 75.0
Latin America Fluconazole 595 13.6 29 24.1 254 7.1 55 81.2
Voriconazole 580 2.4 28 10.7 245 5.3 56 62.5
North America Fluconazole 255 8.1 49 2.0 63 6.3 58 87.9
Voriconazole 255 1.2 49 0.0 63 4.8 58 63.8
a

Isolates were obtained from 133 institutions. The interpretive breakpoints (zone diameters) for resistance (R) were as follows: fluconazole, <14 mm; voriconazole, <13 mm.